Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (171-180 of 491) with videos related to

Pageof 50
Sort By:
Wiener Klinische Wochenschrift|December 22, 2020
Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherenceLisa Steininger, David Chromy, David Bauer, et al.
Wiener Klinische Wochenschrift|December 15, 2015
Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failureMattias Mandorfer, Sebastian Steiner, Philipp Schwabl, et al.
Hepatology (Baltimore, Md.)|November 28, 2019
The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver TransplantationGeorg P Györi, David Pereyra, Benedikt Rumpf, et al.
Cancers|October 17, 2020
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Bernhard Scheiner, Dabin Park, et al.
Gut|December 20, 2012
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranololThomas Reiberger, Gregor Ulbrich, Arnulf Ferlitsch, et al.
Journal of Hepatology|December 25, 2012
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosisThomas Reiberger, Arnulf Ferlitsch, Berit A Payer, et al.
Digestive Diseases and Sciences|December 26, 2019
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on MortalityLukas W Unger, Bernadette Forstner, Moritz Muckenhuber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2019
Prevalence of and risk factors for anaemia in patients with advanced chronic liver diseaseBernhard Scheiner, Georg Semmler, Florian Maurer, et al.
Thrombosis Research|January 16, 2023
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertensionOliver Königsbrügge, Bernhard Scheiner, Benedikt Simbrunner, et al.
Pageof 50

Showing results (171-180 of 491) with videos related to

Sort By:
Pageof 50
Wiener Klinische Wochenschrift|December 22, 2020
Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherenceLisa Steininger, David Chromy, David Bauer, et al.
Wiener Klinische Wochenschrift|December 15, 2015
Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failureMattias Mandorfer, Sebastian Steiner, Philipp Schwabl, et al.
Hepatology (Baltimore, Md.)|November 28, 2019
The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver TransplantationGeorg P Györi, David Pereyra, Benedikt Rumpf, et al.
Cancers|October 17, 2020
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Bernhard Scheiner, Dabin Park, et al.
Gut|December 20, 2012
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranololThomas Reiberger, Gregor Ulbrich, Arnulf Ferlitsch, et al.
Journal of Hepatology|December 25, 2012
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosisThomas Reiberger, Arnulf Ferlitsch, Berit A Payer, et al.
Digestive Diseases and Sciences|December 26, 2019
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on MortalityLukas W Unger, Bernadette Forstner, Moritz Muckenhuber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2019
Prevalence of and risk factors for anaemia in patients with advanced chronic liver diseaseBernhard Scheiner, Georg Semmler, Florian Maurer, et al.
Thrombosis Research|January 16, 2023
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertensionOliver Königsbrügge, Bernhard Scheiner, Benedikt Simbrunner, et al.
Pageof 50